AVGX

Defiance Daily Target 2X Long AVGO ETF
AVGX

29.29 USD
-1.82
5.85%
At close Jun 13, 4:00 PM EDT
After hours
29.16
-0.13
0.44%
1 day
-5.85%
5 days
3.13%
1 month
12.39%
3 months
49.97%
6 months
-6.90%
Year to date
-9.74%
1 year
52.31%
5 years
52.31%
10 years
52.31%
0
Funds holding %
of 7,296 funds
–
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

2.11% less ownership

Funds ownership: 8.0% [Q4 2024] → 5.89% (-2.11%) [Q1 2025]

50% less funds holding

Funds holding: 14 [Q4 2024] → 7 (-7) [Q1 2025]

51% less call options, than puts

Call options by funds: $873K | Put options by funds: $1.8M

62% less capital invested

Capital invested by funds: $8.56M [Q4 2024] → $3.25M (-$5.31M) [Q1 2025]

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for AVGX.

See Analyst Rankings

Financial journalist opinion

Neutral
ETF Trends
1 week ago
Top Performing Leveraged/Inverse ETFs: 06/01/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs: 06/01/2025
Neutral
ETF Trends
6 months ago
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
See News Rankings
Charts implemented using Lightweight Charts™